Inhaled ciclesonide for outpatient treatment of COVID-19 in adults at risk of adverse outcomes: a randomised controlled trial (COVERAGE)

A Duvignaud, E Lhomme, R Onaisi, R Sitta… - Clinical Microbiology …, 2022 - Elsevier
Objectives To assess the efficacy of inhaled ciclesonide in reducing the risk of adverse
outcomes in COVID-19 outpatients at risk of developing severe illness. Methods …

Unfolding the mild to moderate short-term side effects of four COVID-19 vaccines used in Bahrain: a cross-sectional study

MN Zahid - Vaccines, 2021 - mdpi.com
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) created a global
pandemic (COVID-19) that has resulted in massive health and economic losses. The current …

Uptake of the multi-arm multi-stage (MAMS) adaptive platform approach: a trial-registry review of late-phase randomised clinical trials

NM Noor, SB Love, T Isaacs, R Kaplan, MKB Parmar… - BMJ open, 2022 - bmjopen.bmj.com
Background For medical conditions with numerous interventions worthy of investigation,
there are many advantages of a multi-arm multi-stage (MAMS) platform trial approach …

[HTML][HTML] A multi-center, adaptive, randomized, platform trial to evaluate the effect of repurposed medicines in outpatients with early coronavirus disease 2019 (COVID …

G Reis, EASM Silva, DCM Silva… - Gates Open …, 2021 - gatesopenresearch.org
Background: Although vaccines are currently available for coronavirus disease 2019
(COVID-19), there remains a need for an effective and affordable outpatient treatment for …

Implementing an outpatient clinical trial on COVID-19 treatment in an emergency epidemic context: a mixed methods study among operational and research …

C Grenier, M Loniewski, M Plazy, R Onaisi… - Archives of Public …, 2022 - Springer
Background The emergency set-up and implementation of outpatient clinical trials on
epidemic emerging infectious diseases such as COVID-19 raise many issues in terms of …

Key concepts for informed health choices. 1.1: assumptions that treatments are safe or effective can be misleading

AD Oxman, I Chalmers… - Journal of the Royal …, 2022 - journals.sagepub.com
The explanatory essays in The James Lind Library were written to promote wider
understanding of why fair tests of treatments are needed, and what they have come to …

Trial registries for transparency and accountability in clinical research

NJ De Vito - 2022 - ora.ox.ac.uk
Background: Over the past 30 years clinical trial registries have become a key institution
aiming to reduce bias and waste within global clinical research. Funders, journals, and …

Acceptability and feasibility of home and hospital follow-up in Burkina Faso and Guinea: A mixed-method study among patients of the COVID-19 Coverage-Africa …

M Plazy, MH Doucet, C Timbo Songbono… - PLOS Global Public …, 2023 - journals.plos.org
Patient experiences and perspectives on trial participation and follow-up may influence their
compliance with research procedures or negatively impact their well-being. We aimed to …

[PDF][PDF] A Beginner's Guide to Clinical Trials

S Keyes, P Hawley - Canadian Journal of Medicine, 2022 - academia.edu
Study Design Interventions such as medications are studied through a series of phased
trials (Table 1). Therapeutics are first introduced in humans after years of preliminary …

Research on COVID-19 therapy: putting the cart alongside the horse

A Duvignaud, X Anglaret - EBioMedicine, 2021 - thelancet.com
Assessing the efficacy of a new antiviral drug usually starts with in vitro studies, continues
with in vivo animal studies, and ends with studies in humans. Each of these three levels has …